AI Verdict
BSX has stronger fundamentals based on our AI analysis.
BSX vs MRK Fundamental Comparison
| Metric | BSX | MRK |
|---|---|---|
| Revenue | $5.2B | $16.3B |
| Net Income | $1.3B | $-4.2B |
| Net Margin | 25.8% | -26.0% |
| ROE | 5.2% | -9.2% |
| ROA | 3.0% | -3.3% |
| Current Ratio | 1.90x | 1.30x |
| Debt/Equity | 0.42x | 1.02x |
| EPS | $0.90 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BSX vs MRK: Frequently Asked Questions
Is BSX or MRK the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), BSX has stronger fundamentals. BSX is graded A (77% confidence) while MRK is graded B (78% confidence). This is not investment advice.
How does BSX compare to MRK fundamentally?
BOSTON SCIENTIFIC CORP has ROE of 5.2% vs Merck & Co., Inc.'s -9.2%. Net margins are 25.8% vs -26.0% respectively.
Which stock pays higher dividends, BSX or MRK?
BSX has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BSX or MRK for long term?
For long-term investing, consider that BSX has a A grade with 77% confidence, while MRK has a B grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BSX vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BSX vs MRK, the AI consensus favors BSX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.